Literature DB >> 9488719

High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors.

R Urfer1, P Tsoulfas, L O'Connell, J A Hongo, W Zhao, L G Presta.   

Abstract

Neurotrophic factors are important for survival and maintenance of neurons during developmental and adult stages of the vertebrate nervous system. The neurotrophins mediate their signal into the cell by specific interaction with tyrosine kinase receptors of the Trk family. The extracellular immunoglobulin-like domain of the Trk receptors adjacent to the membrane has previously been shown to be the dominant element for specific neurotrophin binding. Using computer graphics models of the human TrkA and TrkC immunoglobulin-like domains as a guide, the residues involved in binding to their respective neurotrophins were mapped by mutational analysis. TrkC primarily utilizes loop EF, between beta-strands E and F, for binding. In contrast, TrkA utilizes the EF loop as well as additional residues, the latter being prime candidates for determining the specificity of TrkA versus TrkC. When selected TrkC and TrkA mutants with reduced binding were expressed on NIH3T3 cells, neurotrophin-induced autophosphorylation was strongly reduced or absent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488719     DOI: 10.1074/jbc.273.10.5829

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor.

Authors:  J C Arevalo; B Conde; B L Hempstead; M V Chao; D Martin-Zanca; P Perez
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 2.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

3.  Molecular simulation of the binding of nerve growth factor peptide mimics to the receptor tyrosine kinase A.

Authors:  Marco Berrera; Antonino Cattaneo; Paolo Carloni
Journal:  Biophys J       Date:  2006-06-23       Impact factor: 4.033

Review 4.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

5.  Crystal structure of the agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK.

Authors:  Amy L Stiegler; Steven J Burden; Stevan R Hubbard
Journal:  J Mol Biol       Date:  2006-09-12       Impact factor: 5.469

Review 6.  Neurotrophin-regulated signalling pathways.

Authors:  Louis F Reichardt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

7.  Neurotrophin-3 Enhances the Synaptic Organizing Function of TrkC-Protein Tyrosine Phosphatase σ in Rat Hippocampal Neurons.

Authors:  Ina Ammendrup-Johnsen; Yusuke Naito; Ann Marie Craig; Hideto Takahashi
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

8.  Postsynaptic TrkC and presynaptic PTPσ function as a bidirectional excitatory synaptic organizing complex.

Authors:  Hideto Takahashi; Pamela Arstikaitis; Tuhina Prasad; Thomas E Bartlett; Yu Tian Wang; Timothy H Murphy; Ann Marie Craig
Journal:  Neuron       Date:  2011-01-27       Impact factor: 17.173

9.  Molecular dynamics simulations of the NGF-TrkA domain 5 complex and comparison with biological data.

Authors:  Giovanni Settanni; Antonino Cattaneo; Paolo Carloni
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

10.  Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3.

Authors:  Ranjana Verma; Peter Holmans; James A Knowles; Deepak Grover; Oleg V Evgrafov; Raymond R Crowe; William A Scheftner; Myrna M Weissman; J Raymond DePaulo; James B Potash; Douglas F Levinson
Journal:  Biol Psychiatry       Date:  2008-03-25       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.